These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18816744)

  • 21. In the case of nonresponse, what is the second-level treatment for induction of remission in Crohn's disease?
    Stange EF
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S251-2. PubMed ID: 18816712
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of postoperative Crohn's disease.
    Ng SC; Kamm MA
    Am J Gastroenterol; 2008 Apr; 103(4):1029-35. PubMed ID: 18371133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How long is it advisable to continue maintenance treatment of Crohn's disease?
    Katz JA
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S264-5. PubMed ID: 18816686
    [No Abstract]   [Full Text] [Related]  

  • 24. ["Metastatic" Crohn's disease of the penis].
    Bloget F; Bisiau S; Delaporte E; Mazeman E; Cortot A; Gosselin B
    Ann Pathol; 1996 Sep; 16(4):296-8. PubMed ID: 9172622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management and prevention of postoperative Crohn's disease.
    Regueiro M
    Inflamm Bowel Dis; 2009 Oct; 15(10):1583-90. PubMed ID: 19322907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgery for Crohn's disease and anti-TNF agents: the changing scenario.
    Sorrentino D; Fogel S; Van den Bogaerde J
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):689-700. PubMed ID: 24161133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial.
    Dignass A; Stoynov S; Dorofeyev AE; Grigorieva GA; Tomsová E; Altorjay I; Tuculanu D; Bunganič I; Pokrotnieks J; Kupčinskas L; Dilger K; Greinwald R; Mueller R;
    J Crohns Colitis; 2014 Sep; 8(9):970-80. PubMed ID: 24534142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic treatment of Crohn's complications.
    Buda A; Okolo PI
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):887-95. PubMed ID: 24849124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative recurrence of Crohn's disease: pathogenesis and prevention.
    D'Haens GR; Rutgeerts PJ
    Acta Gastroenterol Belg; 1994; 57(5-6):311-3. PubMed ID: 7709700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modern surgical tactics in Crohn's disease].
    Poĭda AI; Mel'nik VM; Kucher ND; Zhel'man VA; Krivoruk MI
    Klin Khir; 2015 Jan; (1):5-12. PubMed ID: 25842669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The response of Crohn's strictures to endoscopic balloon dilation.
    Mueller T; Rieder B; Bechtner G; Pfeiffer A
    Aliment Pharmacol Ther; 2010 Mar; 31(6):634-9. PubMed ID: 20047581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of endoscopy in the management of postoperative patients with Crohn's disease.
    Bressler B
    Can J Gastroenterol; 2006 Oct; 20(10):631-2. PubMed ID: 17066151
    [No Abstract]   [Full Text] [Related]  

  • 33. Surgical treatment of Crohn's disease: indications, results and predictive factors of recurrence and morbidity.
    Hefaiedh R; Sabbeh M; Miloudi N; Ennaifer R; Romdhane H; Belhadj N; Gharbi L; Khalfallah T
    Tunis Med; 2015 Jun; 93(6):356-60. PubMed ID: 26644097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of azathioprine in mild or moderate relapse in Crohn's disease: clinical and endoscopic evaluation.
    Murakami Y; Matsui T; Hirai F; Takatsu N; Takaki Y; Nagahama T; Hisabe T; Beppu T; Miyaoka M; Maki S; Takeichi M; Nishimura T; Ueki T; Yao K
    Dig Endosc; 2010 Jan; 22(1):25-32. PubMed ID: 20078661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance of surgically induced remission of Crohn's disease.
    Froehlich F; Juillerat P; Pittet V; Felley C; Mottet C; Vader JP; Michetti P; Gonvers JJ
    Digestion; 2007; 76(2):130-5. PubMed ID: 18239404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of intravenous cyclophosphamide pulse therapy in therapy refractory Crohn's disease patients.
    Hirschmann S; Atreya R; Englbrecht M; Neurath MF
    J Physiol Pharmacol; 2017 Feb; 68(1):57-67. PubMed ID: 28456770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ustekinumab as an Induction Agent for Crohn's Disease of the Pouch.
    Singh A; Ghouri Y; Shen B
    Inflamm Bowel Dis; 2018 Apr; 24(5):e12-e13. PubMed ID: 29668974
    [No Abstract]   [Full Text] [Related]  

  • 38. Endoscopic Evaluation and Management of the Postoperative Crohn's Disease Patient.
    Hashash JG; Binion DG
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):679-92. PubMed ID: 27633596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of Crohn disease recurrence].
    Schölmerich J
    Chirurg; 1998 Sep; 69(9):908-14. PubMed ID: 9816447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How do you judge relapse in Crohn's disease?
    Vatn MH
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S253-4. PubMed ID: 18816713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.